Clinical Research
Clinical research is the systematic investigation of medical treatments, therapies, and interventions to determine their safety and effectiveness. It forms the backbone of modern healthcare, serving as the bridge between scientific discoveries and their real-world application. Here at Pacific Sports and Spine Clinic we believe that research is not just a part of what we do; it’s at the heart of our commitment to exceptional patient care.
Our involvement is driven by a few key principles:
-
- Advancing Treatment Options: We are dedicated to staying at the forefront of medical advances, which allows us to provide our patients with the latest and most effective treatments available.
- Improving Patient Outcomes: Our participation in research studies helps us refine our treatment approaches, leading to better results and experiences for our patients.
- Contributing to the Community: By actively engaging in clinical research, we’re contributing to the broader healthcare community’s knowledge and the betterment of patient care on a global scale.
Our commitment to advancing healthcare through research is unwavering and drives the pursuit of cutting-edge treatments in our clinical research practice. We invite you to explore our website to learn more about our initiatives and how they benefit you, the patient, and the future of healthcare as a whole. Below are the current studies that are enrolling at our facility:
Clinical Trials Open for Enrollment
STABILITY Clinical Trial
The purpose of this study is to evaluate the effectiveness and safety of the instrumented posterior arthrodesis using the Spinal Simplicity Minuteman G5 MIS Fusion Plate and bone graft material in patients with degenerative conditions of the lumbar spine resulting in chronic low back pain with lower extremity symptoms and concurrent neurogenic claudication.
IMPROVE Clinical Trial
The objective of this study is to compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
RESTORE Clinical Trial
VIA Disc NP is a non-surgical intervention intended to supplement nucleus pulposus tissue in degenerated intervertebral discs. This is a randomized, sham-controlled, multi-center, double-blind clinical trial with an open label roll-in period of one participant per site in which participants with lumbar discogenic pain associated with DDD will receive one VIA Disc NP treatment to each affected level (up to 2 levels). Participants enrolled after the roll-in stage will be randomized on a 2:1 basis to receive either a single VIA Disc NP intradiscal injection at 1 or 2 levels or the sham procedure at 1 or 2 levels. At 12 months, participants in the sham arm with continued symptoms may cross-over, receive VIA Disc NP, and will restart the study visit schedule, completing an additional 12 months of follow-up post-cross-over.